Table 4.
Within-group effect sizes (Cohen’s d) for secondary outcomes (PP)
| |
Effect size (Cohen’s d) |
|||
|---|---|---|---|---|
| Baseline to EOT tr-MI |
Baseline to FU tr-MI |
Baseline to EOT TAU |
Baseline to FU TAU |
|
| WHO-5 | 0.52* | 0.55* | 0.05 | 0.13 |
| DSS-20 | 0.35* | 0.71*** | 0.30 | 0.38 |
| SDQ-20 | 0.03 | 0.10 | −0.21 | 0.26 |
| RAAS Close | 0.15 | 0.25 | 0.33 | 0.01 |
| RAAS Depend | 0.28 | 0.15 | 0.00 | 0.05 |
| RAAS Anxiety | 0.15 | 0.35 | −0.07 | −0.40 |
| RAAS Avoidant | 0.24 | 0.23 | 0.23 | 0.26 |
PP: Per Protocol (n = 35/18), WHO-5: Well-being scale; DSS-20: Dissociative Symptoms Scale; SDQ-20: Somatic Dissociation Questionnaire; RAAS: Revised Adult Attachment Scale. Significance levels * p < .05, ** p < .01, *** p < .001 (t-tests).